Why Is Hawthorn Berry In A Men’s Supplement?
A cardiac herb with a Cochrane review sitting first on a men's vitality panel. What its evidence actually covers, why berry is not leaf and flower, and the digoxin interaction.
ErecPower Official Website › Blog
Five long articles on the six botanicals this label names and the timescale it publishes. Three go through individual ingredients, one reconciles the timeline against the refund window, and one works out what six herbs can physically fit inside a single capsule. All five are written by the ErecPower Team and cite the research inline.
Written to be useful to somebody who is not going to buy anything. Two of the five argue against parts of the product this website sells.
A cardiac herb with a Cochrane review sitting first on a men's vitality panel. What its evidence actually covers, why berry is not leaf and flower, and the digoxin interaction.
It inhibits aromatase in a dish and almost none of an oral dose gets past the gut wall. The single human trial, and the conclusion that costs us something.
Two questions with two different answers: the hormone studies found nothing, the questionnaire studies found something, and the argument confuses them.
Three to four weeks across 996 written reviews. Why week one is nothing, why a fast result would be a warning, and which pack fits the refund window.
A size-0 capsule holds 400 to 500 mg. These six botanicals need over three grams a day between them. The arithmetic, and the four fair objections to it.
Every article here starts from something on this product: a botanical name, a number on a graphic, a day count in the order record. None of them starts from a keyword. That is why there is no post called the best male supplement of the year, and why two of the five spend most of their length on what this label does not tell you.
Each one cites its sources inline rather than in a decorative list at the foot. Every PubMed record was confirmed through the NCBI summary API before it was written down, and every government page was opened in a browser and checked against its real page title. That second step matters more than it sounds: the FDA and the NIH Office of Dietary Supplements both refuse a command-line client with what looks exactly like a dead link, and the disclaimer page explains how nearly that cost this site its two best regulatory sources.
Corrections go to [email protected]. They are made on the article itself rather than in a note at the bottom, and the last-updated date moves forward when they are. A date that advances while the content sits still is a signal with no information in it.
Three of the five articles are single-ingredient deep dives, and they were chosen for contrast rather than for balance. Hawthorn has the best trial record and it belongs to cardiology. Tribulus has the most trials and they split into two literatures with two answers. Chrysin has one human trial and it found nothing.
The name with the strongest case, tongkat ali, has no article of its own yet, because the honest version would be four paragraphs long and it is already on the ingredients page.
One article, and it is the one that does the most commercial work while arguing for a smaller order. Three to four weeks is the wait on this desk’s record, the refund window is sixty days from purchase, and the pack that fits both is not the pack that earns us most.
It is also the article with the clearest warning in it: a supplement in this category that works within an hour is a reason to stop rather than to reorder.
One article, and it is the only one on the estate that puts a number on a problem everybody in this aisle talks around. A size-0 capsule holds 400 to 500 mg. These six botanicals need over three grams a day at trial doses.
It also lists the four fair objections to its own argument, because an argument that only survives without objections is not an argument.
The thread running through all five is the same missing figure. This label prints six botanical names and no amount for any of them, so every article here eventually arrives at the same sentence, from a different direction each time.
Everything here is published by the desk that sells the product, which is a reason to read it sceptically rather than a reason not to read it. Five checks make that scepticism productive, and they work on any supplement article anywhere.
Applied here, the answers are meant to be yes five times. The chrysin article ends by saying nobody should buy this product for the chrysin, and the timeline article argues for a smaller pack than the one that pays this desk best. Those two are the ones to read first if you want to know whether the other three are worth your time.
Four article types are missing on purpose, and each absence is a decision rather than a gap in a schedule.
There is no ranking of men’s supplements here, because a ranking published by a seller is an advertisement with numbers on it. If you want a method for comparing products, the nine-point checklist works on any bottle, including a competitor’s and including this one.
No article compares this product to a named rival. A comparison written by one of the two parties is a comparison written to be won, and a reader learns more from a checklist they can apply themselves than from a table somebody else built.
These articles print the doses the trials used. They do not tell you what to take. That is a conversation with a pharmacist, and it goes better with the bottle in your hand than with a blog post in your browser history.
No case studies, no composite customers, no before and after anything. Every person named anywhere on this website is somebody the desk holds a record of, and where the desk holds a photograph but no review text, the photograph is published with that said.
What is here instead is narrow and long: five subjects taken slowly, each starting from something printed on this product. New articles are added when there is something to add rather than on a calendar, and the two most likely additions are both waiting on the manufacturer. A piece about the Supplement Facts panel, if one is ever published. A piece about the certificate of analysis behind the batch reference, if that is ever supplied. Both would be more useful than anything currently planned and neither can be written yet.
If there is a question about this product you expected to find answered here and did not, write to [email protected]. Questions that arrive more than once end up either on the FAQ or, when the answer runs past four paragraphs, as an article on this page.